Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

HIV Testing Critical to Reducing New Infections

By LabMedica International staff writers
Posted on 14 Jul 2011
A three-year initiative to test 2.8 million Americans for Human immunodeficiency virus (HIV) expanded access to testing in 25 United States areas most affected by the virus. More...


The program cost US$111 million and resulted in the diagnosis of 18,432 people who were unaware of their HIV status.

The effort, which was sponsored by the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), ran from October 2007 through September 2010 and helped state and local health departments support routine HIV testing in a variety of health care locations. A main focus was blacks, who are among the US populations most severely affected by HIV.

Although thirty years have passed since the CDC first reported AIDS-like disease, continuing to raise awareness about HIV and encouraging people to be tested remain important public health goals. Illinois Department of Public Health director Dr. Damon T. Arnold said, "On the 30th anniversary of the awareness of the disease, it remains critically important for people to get tested, know their HIV status, and be knowledgeable about their lives and health."

CDC currently funds 30 areas to reach populations at a higher risk for HIV, including African-Americans, gay, and bisexual men, Latinos, and injection drug users. The CDC launched its expanded testing to support 2006 recommendations for HIV testing to become a routine part of health care for adolescents and adults.

The three-year initiative's focus on testing African-Americans was successful, the centers reported. Hospital emergency rooms, STD clinics, and community-based organizations were three important types of venues in which testing occurred. Chicago was one of the 25 jurisdictions featured in the initiative.

Dr. Kevin Fenton, director of CDC's National Center for HIV/AIDS, Viral Hepatitis, sexually transmitted diseases (STD) and tuberculosis (TB) prevention, was quoted as saying in a recent CDC news release. "These results demonstrate that the nation is making steady progress toward that vision. But more than half of US adults aged 18 to 64 still have never been tested for HIV, and our work is far from over."

Related Links:
US Centers for Disease Control and Prevention




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.